Fig. 2 | Hypertension Research

Fig. 2

From: Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist

Fig. 2

Body weight (a), kidney weight (b), heart weight (c), and left ventricular wall thickness (d) of control, DOCA-salt, DOCA-salt + MH-76–treated, DOCA-salt + MH-79–treated and DOCA-salt + prazosin-treated rats at the end of the experimental period. Values are expressed as means ± SEM (n = 6–8), *P < 0.05, **P < 0.01, ***P < 0.001 vs. control; #P < 0.05, ##P < 0.01 vs. DOCA-salt, (one-way ANOVA, post hoc Bonferroni test)

Back to article page